Literature DB >> 22528230

Primary screening for breast diseases among 17618 women in Wufeng area, a region with high incidence of cervical cancer in China.

Qinghua Zhang1,2, Dan Liu1, Chuanying Hang3, Ting Hu1, Jian Shen1, Meiling Hu3, Ru Yang1, Zhilan Chen1, Zhuhui Lai3, Guiling Liu3, Yedong Mei3, Qunying Xiang3, Xiong Li1, Kecheng Huang1, Shaoshuai Wang1, Xiuyu Pan1, Yuting Yan1, Ye Li1, Qian Chen1, Lin Xi1, Dongrui Deng1, Hui Wang1, Shixuan Wang1, Yunping Lu1, Ding Ma1, Shuang Li4.   

Abstract

In this study, the current status for breast diseases in a region with high-incidence of cervical cancer were epidemiologically investigated. From March to August, 2009, 17618 women, from Wufeng area of Hubei province, China, were recruited to screen breast diseases by using breast infrared diagnostic apparatus. Other diagnostic methods, such as B-mode ultrasound, X-ray mammography, needle biopsy and pathological examination were, if necessary, used to further confirm the diagnosis. The screening showed that 5990 of 17618 cases (34.00%) had breast diseases, 5843 (33.16%) had mammary gland hyperplasia, 48 (0.27%) had breast fibroadenoma, 11 (0.06%) had breast carcinoma, and 88 (0.50%) had other breast diseases. The peak morbidity of breast cancer was found in the women aged 50-60 ages. The morbidity of breast cancer was significantly increased in women elder than or equal to 50 years old (n=8, 0.157%) in comparison with that in the subjects younger than 50 years old (n=3, 0.024%) (u=2.327, P<0.05). It was shown that the occurrence of breast diseases was concentrated in women aged 20-40 years, while the total morbidity reached its peak at the age of 30 years and then decreased sharply after age of 40. Compared with the patients elder than or equal to 40 years old (n=3289, 27.46%), the morbidity rate of breast diseases was significantly increased in women less than 40 years old (2648 cases, 47.18%; P<0.001). However, there was no significant difference in the morbidity of breast diseases between the age group of 20-29 years and that of 30-39 years (P=0.453), and both of them were high. There was no significant association between the morbidity of breast diseases and cervical cancer. Since the morbidity of breast diseases was higher among young women, more attention should be paid to the screening of breast diseases among young women for early diagnosis.

Entities:  

Mesh:

Year:  2012        PMID: 22528230     DOI: 10.1007/s11596-012-0045-3

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

Review 1.  Cancer burden in the year 2000. The global picture.

Authors:  D M Parkin; F I Bray; S S Devesa
Journal:  Eur J Cancer       Date:  2001-10       Impact factor: 9.162

2.  [Analysis of risk factors for cervical cancer in Xiangyuan County, Shanxi Province].

Authors:  Shoude Rong; Wen Chen; Lingying Wu; Xun Zhang; Guihua Shen; Yunyuan Liu; Fanghui Zhao; Junfei Ma; Youlin Qiao
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2002-01

3.  [Feasibility of packaging screening for cervical cancer, breast cancer, and reproductive tract infection in a rural area in China].

Authors:  Wang Xiang; Fang-Hui Zhao; Jü-Fang Shi; Zhi-Xia Li; Jun-Fei Ma; You-Lin Qiao; Yan Wang
Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao       Date:  2009-10

Review 4.  Hormonal contraception and risk of cancer.

Authors:  D Cibula; A Gompel; A O Mueck; C La Vecchia; P C Hannaford; S O Skouby; M Zikan; L Dusek
Journal:  Hum Reprod Update       Date:  2010-06-12       Impact factor: 15.610

5.  Benign breast disease and the risk of breast cancer.

Authors:  Lynn C Hartmann; Thomas A Sellers; Marlene H Frost; Wilma L Lingle; Amy C Degnim; Karthik Ghosh; Robert A Vierkant; Shaun D Maloney; V Shane Pankratz; David W Hillman; Vera J Suman; Jo Johnson; Cassann Blake; Thea Tlsty; Celine M Vachon; L Joseph Melton; Daniel W Visscher
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

6.  Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.

Authors:  Maria J Worsham; Usha Raju; Mei Lu; Alissa Kapke; Jingfang Cheng; Sandra R Wolman
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

7.  Relationship between the expression of telomerase and human papillomavirus infection in invasive uterine cervical carcinoma.

Authors:  Ni Sima; Liping Cai; Yuanfang Zhu; Wei Wang; Shixuan Wang; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-08

8.  Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.

Authors:  Laszlo Tabar; Ming-Fang Yen; Bedrich Vitak; Hsiu-Hsi Tony Chen; Robert A Smith; Stephen W Duffy
Journal:  Lancet       Date:  2003-04-26       Impact factor: 79.321

9.  HPV screening for cervical cancer in rural India.

Authors:  Rengaswamy Sankaranarayanan; Bhagwan M Nene; Surendra S Shastri; Kasturi Jayant; Richard Muwonge; Atul M Budukh; Sanjay Hingmire; Sylla G Malvi; Ranjit Thorat; Ashok Kothari; Roshan Chinoy; Rohini Kelkar; Shubhada Kane; Sangeetha Desai; Vijay R Keskar; Raghevendra Rajeshwarkar; Nandkumar Panse; Ketayun A Dinshaw
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

Review 10.  The woman at high risk for breast cancer. Importance of hyperplasia.

Authors:  D L Page
Journal:  Surg Clin North Am       Date:  1996-04       Impact factor: 2.741

  10 in total
  2 in total

1.  MicroRNA-215 is a potential prognostic marker for cervical cancer.

Authors:  Hua Liang; Yan Li; Ruo-Yu Luo; Fu-Jin Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-04-08

2.  Knowledge about cervical cancer and barriers of screening program among women in Wufeng County, a high-incidence region of cervical cancer in China.

Authors:  Yao Jia; Shuang Li; Ru Yang; Hang Zhou; Qunying Xiang; Ting Hu; Qinghua Zhang; Zhilan Chen; Ding Ma; Ling Feng
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.